October 23, 2026, Heineken warned that the growing use of GLP-1 weight-loss drugs could lead to fewer pints of beer being sold in UK pubs and restaurants. Heineken urged businesses to adjust their drink selections by offering more smaller servings, as well as low-alcohol and alcohol-free drinks, to address potential changes in consumers’ drinking habits.

The warning points to possible changes in both the volume and mix of drinks consumed. For pubs and restaurants, smaller servings could be one way to meet demand if consumers drink less on each occasion. Low-alcohol and alcohol-free drinks could attract more attention if consumers’ demand for alcohol declines. These changes reflect different consumer choices, and their actual impact will depend on how consumers adjust their ordering habits.

A change in the number of pints of beer sold does not necessarily translate into a proportional change in drink revenue. Smaller servings change the volume per drink, while low-alcohol and alcohol-free drinks involve changes to the product mix. Assessing the impact on business therefore requires looking at the number of drinks sold, the total volume consumed, and the sales performance of different drinks to distinguish reduced consumption from a shift in demand.

Heineken’s statement is currently a warning about potential changes in demand; it does not mean that pubs and restaurants in the UK have already seen beer sales decline as a result of the growing use of weight-loss drugs. Going forward, it will be worth watching whether consumers continue to drink less beer and whether businesses can meet changing demand for drinks by adding smaller servings and low-alcohol and alcohol-free options.